ArticleCancer immunology, immunotherapy : CII2021

Merkel cell carcinoma in Latin America: a contribution from an expanded access program for avelumab to address issues from experts' recommendations.

Rodrigo Ramella Munhoz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.